Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2000
10/19/2000CA2369578A1 Compounds and methods for therapy and diagnosis of lung cancer
10/19/2000CA2369413A1 Transmembrane protein expressed in prostate and other cancers
10/19/2000CA2366520A1 Anti-bacterial vaccine compositions
10/19/2000CA2365918A1 49 human secreted proteins
10/19/2000CA2365917A1 Bone morphogenic proteins
10/19/2000CA2365915A1 Recombinant toxin a/toxin b vaccine against clostridium difficile
10/19/2000CA2365914A1 Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
10/19/2000CA2365913A1 Tumor necrosis factor receptor homologs and nucleic acids encoding the same
10/19/2000CA2365912A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
10/19/2000CA2365910A1 Human proteins and polynucleotides encoding them
10/19/2000CA2365905A1 48 human secreted proteins
10/19/2000CA2365623A1 Tyrosine kinase substrate (tks) proteins
10/19/2000CA2365522A1 48 human secreted proteins
10/19/2000CA2364577A1 Regulation of repressor genes using nucleic acid molecules
10/18/2000EP1045028A1 Deoxyribonucleases
10/18/2000EP1045023A1 Serum free medium
10/18/2000EP1044983A1 Antibiotic tkr2999, process for the preparation thereof and microbe
10/18/2000EP1044273A2 COMPOSITIONS DERIVED FROM $i(MYCOBACTERIUM VACCAE) AND METHODS FOR THEIR USE
10/18/2000EP1044271A1 Il-1 delta dna and polypeptides
10/18/2000EP1044269A1 Human vps35/mem3-related protein
10/18/2000EP1044266A2 Human signal peptide-containing proteins
10/18/2000EP1044220A1 Secreted proteins and polynucleotides encoding them
10/18/2000EP1044219A1 DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEIN, nNR5
10/18/2000EP1044218A1 Nucleic acids encoding transferrin receptor-like proteins and products related thereto
10/18/2000EP1044212A1 Human fk506 binding proteins
10/18/2000EP1044210A1 Human dendriac and brainiac-3
10/18/2000EP1044024A1 Use of pigmented retinal epithelial cells for creation of an immune privilege site
10/18/2000EP1044020A2 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products
10/18/2000EP0876385B1 Topiramate immunoassay, as well as analogs and antibodies
10/18/2000EP0467932B1 Urokinase-type plasminogen activator receptor
10/18/2000CN1270637A Isolation of a novel senescence-factor gene, P23
10/18/2000CN1270635A Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these protein
10/18/2000CN1270632A APPIL-a novel protein with growth effects
10/18/2000CN1270061A 弯曲菌疫苗 Campylobacter vaccine
10/18/2000CN1057567C Colone and/or express vectors, process of production and use thereof
10/18/2000CN1057564C Microbe capable of producing active recombinant phycabiliprotein and its preparing method
10/18/2000CN1057535C Process for producing hydrophobic polypeptides proteins or peptides
10/18/2000CN1057534C Erythropoietin analogs
10/18/2000CN1057533C Method for producing clostridium perfringers vaccines
10/18/2000CN1057532C Process for purifying hepatitis B viral surface antigen comprising PRES2 peptide
10/17/2000US6133427 Anti-human calcitonin monoclonal antibodies and an immunoassay utilizing said antibodies
10/17/2000US6133017 Attenuated strain of Leishmania
10/17/2000US6133015 HHV-8+ lymphoma cell line which is HIV-, CMV-, EBV-, and which produces large amounts of uncontaminated HHV-8 virus
10/17/2000US6133011 Chimeric proteins having fibrinolytic and thrombin-inhibiting properties
10/17/2000US6133007 Phosphodiesterase 8A
10/17/2000US6133005 Enzymatic protein; for the treatment of nervous system disorders associated with thamine vitamin deficiency
10/17/2000US6132992 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
10/17/2000US6132991 Human interleukin-3 (IL-3) variant fusion proteins
10/17/2000US6132987 Polypeptide associated with macrophages; for diagnosis and treatment of inflammation, arthritis and atherosclerosis
10/17/2000US6132980 Antibodies specific for TRP-2 a human tumor antigen recognized by cytotoxic T lymphocytes
10/17/2000US6132973 Nucleotide sequence coding protein associated with gene expression; for the diagnosis, prevention, and treatment of defects associated with cell proliferation
10/17/2000US6132970 Rearranging nucleotide sequences; extending chains of nucleotide sequence with regions of both homogeneity and heterogeneity in multiple cycles, screening rearranged nucleotide sequences to detect desired properties
10/17/2000US6132960 Envelope polypeptide; for the detection of plant parasite
10/17/2000US6132734 Cloning of mite allergens
10/17/2000US6132733 Ringworm vaccine
10/17/2000US6132732 Parvovirus capsids
10/17/2000US6132731 Murine leukemia virus vectors
10/17/2000US6132728 Hedgehog-derived polypeptides
10/17/2000US6132721 Non-Toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same
10/17/2000US6132719 Produced by digesting human fibrinogen with granulocyte elastase and d-domain-containing digestion products produced by digesting human stabilized fibrin with granulocyte elastase
10/17/2000US6132718 Using a vaccine comprising antibodies and anti-idiotype antibodies that mimic an epitope of antigen that is associated with a tumor or infectious agent.
10/17/2000US6132717 Administering to said mammals an endoproteolytically active amount of furin produced by a eukaryotic host cell.
10/17/2000US6132716 Thermostable xylanases from Microtetraspora flexuosa as a feed additive
10/17/2000CA2104899C Antibodies to plasmodium falciparum
10/17/2000CA2068320C Production of recombinant human interleukin-1 inhibitor
10/17/2000CA1341123C Filamentous hemagglutinin of b. pertussis
10/17/2000CA1341121C Enod2 gene regulatory region
10/17/2000CA1341118C Nucleic acid and methods for the synthesis of novel decay accelerating factor compositions
10/17/2000CA1341116C Yeast expression systems with vectors having gapdh or pyk promoters and synthesis or foreign protein
10/12/2000WO2000060100A1 Dsp-9 dual-specificity map kinase phosphatase
10/12/2000WO2000060099A1 Dsp-4 dual-specificity map kinase phosphatase
10/12/2000WO2000060098A1 Dsp-7 dual-specificity map kinase phosphatase
10/12/2000WO2000060090A1 Compounds and methods for the diagnosis and treatment of b. microti infection
10/12/2000WO2000060082A2 Vesicle associated proteins
10/12/2000WO2000060080A2 Molecules of the immune system
10/12/2000WO2000060077A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
10/12/2000WO2000060075A1 Novel proteins, gene encoding the same and method of utilization thereof
10/12/2000WO2000059943A2 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE
10/12/2000WO2000059942A2 Human obesity protein binding protrein-2 homolog and uses thereof
10/12/2000WO2000059941A1 Purposeful movement of human migratory cells away from an agent source
10/12/2000WO2000059936A1 Human neurogenin 3-encoding nucleotide sequences
10/12/2000WO2000059933A2 HUMAN MESENCHYMAL DNAs AND EXPRESSION PRODUCTS
10/12/2000WO2000037494A3 Chlamydia trachomatis antigens
10/12/2000WO2000025722A3 ENHANCED VACCINES COMPRISING SELF AND NON-SELF IgE PORTIONS OR DIMERIC ANTIGENS
10/12/2000WO2000023594A9 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP)
10/12/2000WO2000020587A3 Cancer associated antigens and uses therefor
10/12/2000WO2000020449A3 MODIFIED TGF-β SUPERFAMILY PROTEINS
10/12/2000WO1997036919A3 Cytokine designated lerk-8
10/12/2000DE10004815A1 Human sodium-phosphate cotransporter Npt2B, useful e.g. for identifying agents for treating hyper- and hypo-phosphatemia, and related nucleic acid
10/12/2000CA2367403A1 Dsp-9 dual-specificity map kinase phosphatase
10/12/2000CA2367378A1 Molecules of the immune system
10/12/2000CA2367109A1 Dsp-4 dual-specificity map kinase phosphatase
10/12/2000CA2367104A1 Dsp-7 dual-specificity map kinase phosphatase
10/12/2000CA2365961A1 Human neurogenin 3-encoding nucleotide sequences
10/12/2000CA2365421A1 Vesicle associated proteins
10/12/2000CA2365397A1 Novel proteins, gene encoding the same and method of utilization thereof
10/12/2000CA2365040A1 Hob-bp2h compositions, methods and uses thereof
10/11/2000EP1043395A1 Novel guanosine triphosphate (gtp)-binding protein conjugate type receptor proteins
10/11/2000EP1043394A2 Combination containing prostate-specific-antigen (PSA)
10/11/2000EP1043335A1 Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
1 ... 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 ... 1125